TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 7, 2008, Pages 3151-3157

  Yamaji, Yoko ^a   Yoshida, Shigeo ^a,b   Ishikawa, Keijiro ^a   Sengoku, Akihito ^a   Sato, Kota ^c   Yoshida, Ayako ^a   Kuwahara, Rumi ^a   Ohuchida, Kenoki ^a   Oki, Eiji ^a   Enaida, Hiroshi ^a   Fujisawa, Kimihiko ^a   Kono, Toshihiro ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR ENDOTHELIAL MARKER 7; TUMOR PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ISOPROTEIN; PLXDC1 PROTEIN, HUMAN;

ADULT; ARTICLE; CD34 SELECTION; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FIBROVASCULAR MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA PROBE; RNA SEQUENCE; RNA SPLICING; UPREGULATION; VITRECTOMY; AGED; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; METABOLISM; MIDDLE AGED; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEOPLASM PROTEINS; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; RETINAL NEOVASCULARIZATION; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 48249156147     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1249     Document Type: Article

References (49)

1. Dorrell M, Uusitalo-Jarvinen H, Aguilar E, Friedlander M. Ocular neovascularization: basic mechanisms and therapeutic advances. Surv Ophthalmol. 2007;52(suppl 1):S3-S19. (Pubitemid 46107520)
2. Yoshida A, Yoshida S, Ishibashi T, Inomata H. Intraocular neovascularization. Histol Histopathol. 1999;14:1287-1294. (Pubitemid 29447469)
3. Hiscott P, Wong D, Grierson I. Challenges in ophthalmic pathology: the vitreoretinal membrane biopsy. Eye. 2000;14(pt 4):549-559. (Pubitemid 30673953)
4. Kociok N, Joussen AM. Varied expression of functionally important genes of RPE and choroid in the macula and in the periphery of normal human eyes. Graefes Arch Clin Exp Ophthalmol. 2007;245:101-113. (Pubitemid 46766736)
5. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487. (Pubitemid 24356306)
6. Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH. Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci. 2001;42:1586-1591. (Pubitemid 32520752)
7. Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye. 2006;20:1366-1369. (Pubitemid 44921137)
8. Ozaki H, Hayashi H, Oshima K. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy. Ophthalmic Res. 1996;28:356-360. (Pubitemid 27051149)
9. Watanabe D, Suzuma K, Suzuma I, et al. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2005;139:476-481. (Pubitemid 40379074)
10. Simo R, Vidal MT, Garcia-Arumi J, et al. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Res Clin Pract. 2006;71:36-44. (Pubitemid 41821141)
11. Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res. 1995;14:1045-1053.
12. Mitamura Y, Harada T, Harada C, et al. NF-κB in epiretinal membranes after human diabetic retinopathy. Diabetologia. 2003;46:699-703. (Pubitemid 36808190)
13. Mitamura Y, Okumura A, Harada C, et al. Activator protein-1 in epiretinal membranes of patients with proliferative diabetic retinopathy. Diabetologia. 2006;49:209-211. (Pubitemid 43151634)
14. Yoshida A, Yoshida S, Khalil AK, Ishibashi T, Inomata H. Role of NF-κB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci. 1998;39:1097-1106. (Pubitemid 28247343)
15. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol. 2004;242:409-413. (Pubitemid 38801529)
16. Yoshida S, Yoshida A, Ishibashi T, Elner SG, Elner VM. Role of MCP-1 and MIP-1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol. 2003;73:137-144. (Pubitemid 36125684)
17. Duh EJ, Yang HS, Haller JA, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol. 2004;137:668-674. (Pubitemid 38446681)
18. Suzuma K, Takagi H, Otani A, Oh H, Honda Y. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. Am J Pathol. 1999;154:343-354. (Pubitemid 29094085)
19. Nanda A, St Croix B. Tumor endothelial markers: new targets for cancer therapy. Curr Opin Oncol. 2004;16:44-49. (Pubitemid 38703471)
20. St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science. 2000;289:1197-1202. (Pubitemid 30650733)
21. Wang XQ, Sheibani N, Watson JC. Modulation of tumor endothelial cell marker 7 expression during endothelial cell capillary morphogenesis. Microvasc Res. 2005;70:189-197. (Pubitemid 41586472)
22. Nanda A, Buckhaults P, Seaman S, et al. Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res. 2004;64:8507-8511. (Pubitemid 39552060)
23. Fuchs B, Mahlum E, Halder C, et al. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene. 2007;399:137-143. (Pubitemid 47211668)
24. Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol. 1997;17:4015-4023. (Pubitemid 27281877)
25. Yoshida S, Yamaji Y, Yoshida A, et al. Novel triple missense mutations of GUCY2D gene in Japanese family with cone-rod dystrophy: possible use of genotyping microarray. Mol Vis. 2006;12:1558-1564. (Pubitemid 46029769)
26. Yoshida S, Yoshida A, Nakao S, et al. Lattice corneal dystrophy type I without typical lattice lines: role of mutational analysis. Am J Ophthalmol. 2004;137:586-588. (Pubitemid 38328665)
27. Yoshida S, Yamaji Y, Yoshida A, Noda Y, Kumano Y, Ishibashi T. Rapid genotyping for most common TGFBI mutations with real-time polymerase chain reaction. Hum Genet. 2005;116:518-524. (Pubitemid 41166782)
28. Yoshida S, Yamaji Y, Yoshida A, Ikeda Y, Yamamoto K, Ishibashi T. Rapid detection of SAG 926delA mutation using real-time polymerase chain reaction. Mol Vis. 2006;12:1552-1557. (Pubitemid 46029770)
29. Yoshida S, Yamaji Y, Kuwahara R, et al. Novel mutation in exon 2 of COL2A1 gene in Japanese family with Stickler syndrome type I. Eye. 2006;20:743-745. (Pubitemid 43880607)
30. Yoshida S, Kumano Y, Yoshida A, et al. Two brothers with gelatinous drop-like dystrophy at different stages of the disease: role of mutational analysis. Am J Ophthalmol. 2002;133:830-832. (Pubitemid 34580636)
31. Yoshida S, Kumano Y, Yoshida A, et al. An analysis of BIGH3 mutations in patients with corneal dystrophies in the Kyushu district of Japan. Jpn J Ophthalmol. 2002;46:469-471. (Pubitemid 35286602)
32. Yoshida S, Honda M, Yoshida A, et al. Novel mutation in ABCC6 gene in a Japanese pedigree with pseudoxanthoma elasticum and retinitis pigmentosa. Eye. 2005;19:215-217. (Pubitemid 40309509)
33. Yoshida S, Arita R, Yoshida A, et al. Novel mutation in FZD4 gene in a Japanese pedigree with familial exudative vitreoretinopathy. Am J Ophthalmol. 2004;138:670-671. (Pubitemid 39420509)
34. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101-111. (Pubitemid 24046832)
35. Yoshida A, Yoshida S, Ishibashi T, Kuwano M, Inomata H. Suppression of retinal neovascularization by the NF-κB inhibitor pyrrolidine dithiocarbamate in mice. Invest Ophthalmol Vis Sci. 1999;40:1624-1629. (Pubitemid 29252358)
36. Yoshida S, Yoshida A, Ishibashi T, Kumano Y, Matsui T. Presence of vitronectin in neovascularized cornea of patient with gelatinous drop-like dystrophy. Br J Ophthalmol. 2003;87:368-369. (Pubitemid 36307924)
37. Yoshida A, Yoshida S, Hata Y, Khalil AK, Ishibashi T, Inomata H. The role of NF-κB in retinal neovascularization in the rat: possible involvement of cytokine-induced neutrophil chemoattractant (CINC), a member of the interleukin-8 family. J Histochem Cytochem. 1998;46:429-436. (Pubitemid 28158462)
38. Yoshida A, Kawano Y, Kato K, et al. Apoptosis in perforated cornea of a patient with graft-versus-host disease. Can J Ophthalmol. 2006;41:472-475. (Pubitemid 44298961)
39. Yoshida S, Yoshida A, Matsui H, Takada Y, Ishibashi T. Involvement of macrophage chemotactic protein-1 and interleukin-1beta during inflammatory but not basic fibroblast growth factor-dependent neovascularization in the mouse cornea. Lab Invest. 2003;83:927-938. (Pubitemid 36899060)
40. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 2001;61:6649-6655. (Pubitemid 32896479)
41. Martin AJ, Clark F, Smith CWJ. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol. 2005;6:386-398. (Pubitemid 40637856)
42. Licatalosi DD, Darnell RB. Splicing regulation in neurologic disease. Neuron. 2006;52:93-101. (Pubitemid 44466357)
43. Davis MJ, Hanson KA, Clark F, et al. Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units. PLoS Genet. 2006;2:e46.
44. Srebrow A, Kornblihtt AR. The connection between splicing and cancer. J Cell Sci. 2006;119:2635-2641. (Pubitemid 44184000)
45. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113:1695 e1691-1615. (Pubitemid 44442453)
46. Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005;5:436-446. (Pubitemid 40791486)
47. Lee HK, Seo IA, Park HK, Park HT. Identification of the basement membrane protein nidogen as a candidate ligand for tumor endothelial marker 7 in vitro and in vivo. FEBS Lett. 2006;580:2253-2257.
48. Lee HK, Bae HR, Park HK, et al. Cloning, characterization and neuronal expression profiles of tumor endothelial marker 7 in the rat brain. Brain Res Mol Brain Res. 2005;136:189-198. (Pubitemid 40704622)
49. McLeod DS, D'Anna SA, Lutty GA. Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci. 1998;39:1918-1932. (Pubitemid 28397274)